Less Ads, More Data, More Tools Register for FREE

Scrip dividend election & directors' shareholdings

1 Nov 2013 07:00

RNS Number : 6425R
Wynnstay Group PLC
01 November 2013
 



AIM: WYN

 

 

Wynnstay Group plc

(the "Company")

 

Scrip dividend election and Directors' shareholdings

 

The Company announces the following information in relation to the ordinary share capital of the Company:

 

Elections to accept the scrip dividend alternative with regard to the interim dividend for the year ended 31 October 2013 paid on 31 October 2013 were received from the holders of 3,336,619 ordinary shares of 25p each in the Company ("Ordinary Shares"), in aggregate, representing approximately 19.9% of the Ordinary Shares in issue on 27 September 2013, being the record date for the final dividend. Accordingly, 17,861 new Ordinary Shares have been issued in satisfaction of such elections at an equivalent price of £5.749 each, increasing the enlarged issued Ordinary Share capital of the Company to 18,850,167 Ordinary Shares. The additional cost to the Company of the dividend paid in cash amounts to approximately £417,132 in total.

 

In the issue, the following directors received new Ordinary Shares in lieu of cash dividends:

 

Name

No. of new Ordinary Shares

New shareholding

% of enlarged Ordinary Share capital

Mr D.A.T. Evans

70

18,965

0.10%

Mr J.C. Kendrick

55

10,375

0.06%

Lord Carlile

176

32,909

0.17%

 

 

Application has been made for the new Ordinary Shares to be admitted to trading on AIM. Dealings are expected to commence on 7 November 2013.

 

For further details please contact:

 

Wynnstay Group plc

Ken Greetham, Chief Executive

Paul Roberts, Finance Director

T: 01691 828512

 

Biddicks

Katie Tzouliadis / Alexandra Shilov

T: 020 3178 6378

Shore Capital (Nomad and Broker)

Stephane Auton / Patrick Castle

T: 020 7408 4090

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGGRCUUPWGGB

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS